Drug Profile
Modified Bromelain-Rx - Anatara Lifesciences
Alternative Names: Detach™Latest Information Update: 05 Jan 2022
Price :
$50
*
At a glance
- Originator Anatara Lifesciences
- Class Anti-inflammatories; Antidiarrhoeals; Cysteine endopeptidases; Skin disorder therapies
- Mechanism of Action Bacterial growth inhibitors; Inflammation mediator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Diarrhoea
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for phase-I development in Diarrhoea in Australia
- 07 Oct 2016 Modified Bromelain-Rx is available for licensing as of 07 Oct 2016. http://anataralifesciences.com/
- 07 Oct 2016 Phase-I clinical trials in Diarrhoea in Australia (unspecified route) prior to October 2016